ALPI

ALPI Molekülinformation

Englischer Name	Intestinal alkaline phosphatase	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1	Target-Alias	IAP，Intestinal-type alkaline phosphatase，Intestinal-Type Alkaline Phosphatase，Alkaline Phosphomonoesterase，Glycerophosphatase，Kasahara Isozyme
Höchste Forschungs- und Entwicklungsphase	Phase 1 Clinical

Englischer Name	Intestinal alkaline phosphatase
Target-Alias	IAP，Intestinal-type alkaline phosphatase，Intestinal-Type Alkaline Phosphatase，Alkaline Phosphomonoesterase，Glycerophosphatase，Kasahara Isozyme
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1
Höchste Forschungs- und Entwicklungsphase	Phase 1 Clinical

ALPI Produktliste

Attribut
Protein (4)
Produktbibliothek
Online (4)
Spezies
Human (2)Cynomolgus (1)Mouse (1)
Etikett
His Tag (3)His Tag & Avi Tag (1)
Marker
Unconjugated (3)Biotin-labeled (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
ALI-H52H3	Human	HEK293	Human ALPI Protein, His Tag (active enzyme, MALS verified)	In den Warenkorb legen
ALI-H82E3	Human	HEK293	Biotinylated Human ALPI Protein, His,Avitag™ (active enzyme, MALS verified)	In den Warenkorb legen
ALI-M52H4	Mouse	HEK293	Mouse ALPI Protein, His Tag (active enzyme, MALS verified)	In den Warenkorb legen
ALI-C52H3	Cynomolgus	HEK293	Cynomolgus ALPI Protein, His Tag (MALS verified)	In den Warenkorb legen

Gesamtmenge4

ALPI Molekülhintergrund

There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The intestinal alkaline phosphatase gene encodes a digestive brush-border enzyme. This enzyme is a component of the gut mucosal defense system and is thought to function in the detoxification of lipopolysaccharide, and in the prevention of bacterial translocation in the gut.

ALPI Molekülalias

IAP

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Oral alkaline phosphatase (Synthetic Biologics)	SYN-020	Phase 1 Clinical	Massachusetts General Hospital, Theriva Biologics Inc	Celiac Disease; Enteritis; Inflammatory Bowel Diseases; Metabolic Syndrome	Details